The market model places Biosense Webster, Abbott and Medtronic as market leaders. "Kardium’s pulsed field ablation clinical trial enters final stages" was originally created and published by ...

While several effective treatment options for AFib exist, current evidence strongly suggests that pulsed field ablation (PFA) ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

In January 2024, Abbott announced that the first global procedures had been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal ...

With the introduction of pulsed-field ablation, patients can have a non-thermal form of ablation. This technology delivers pulsed electrical fields through an ablation catheter to selectively ...

The Clarivate e-book highlights new medtech breakthroughs in the pulsed field ablation (PFA) market, forecasting its future growth and showcasing the technology's potential to transform the ...

Steven Mickelsen, the electrophysiologist who founded Farapulse before it was sold to Boston Scientific in 2021, is taking pulsed field ablation into new territory with the development of a device ...

After more than a monthlong pause in response to four neurovascular events linked to its Varipulse pulsed-field ablation system, Johnson & Johnson announced late last week that it will resume use of ...